Thermo Fisher Scientific Inc.  

(Public, NYSE:TMO)   Watch this stock  
Find more results for Seth D Harris´┐Ż
156.89
+0.69 (0.44%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 156.02 - 157.37
52 week 117.10 - 158.37
Open 156.82
Vol / Avg. 901,937.00/1.47M
Mkt cap 61.15B
P/E 31.52
Div/yield 0.15/0.38
EPS 4.98
Shares 393.51M
Beta 1.04
Inst. own 90%
Jul 28, 2016
Q2 2016 Thermo Fisher Scientific Inc Earnings Release - 9:30AM EDT - Add to calendar
Jul 28, 2016
Q2 2016 Thermo Fisher Scientific Inc Earnings Call - 8:30AM EDT - Add to calendar
May 27, 2016
Thermo Fisher Scientific Inc Conference Call to Discuss its Definitive Agreement to Acquire FEI Co - Webcast
May 19, 2016
Thermo Fisher Scientific Inc Annual Shareholders Meeting (Estimated)
May 18, 2016
Thermo Fisher Scientific Inc Annual Shareholders Meeting
May 18, 2016
Thermo Fisher Scientific Inc Analyst Meeting
May 10, 2016
Thermo Fisher Scientific Inc at Bank of America Merrill Lynch Health Care Conference
Apr 28, 2016
Q1 2016 Thermo Fisher Scientific Inc Earnings Release
Apr 28, 2016
Q1 2016 Thermo Fisher Scientific Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '16) 2015
Net profit margin 9.37% 11.67%
Operating margin 12.06% 13.77%
EBITD margin - 24.73%
Return on average assets 3.85% 4.73%
Return on average equity 7.63% 9.45%
Employees 52,000 -
CDP Score - 77 D

Address

81 Wyman St, PO Box 9046
WALTHAM, MA 02451-1223
United States - Map
+1-781-6221000 (Phone)
+1-781-6221207 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory.

Officers and directors

Jim P. Manzi Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Marc N. Casper President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen Williamson Chief Financial Officer, Senior Vice President
Age: 49
Bio & Compensation  - Reuters
Peter M. Wilver Executive Vice President, Chief Administrative Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark P. Stevenson Executive Vice President, President, Life Sciences Solutions
Age: 53
Bio & Compensation  - Reuters
Seth H. Hoogasian Senior Vice President, General Counsel, Secretary
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Patrick M. Durbin Senior Vice President, President - Specialty Diagnostics
Age: 49
Bio & Compensation  - Reuters
Thomas W. Loewald Senior Vice President, Chief Commercial Officer
Age: 52
Bio & Compensation  - Reuters
Daniel P. Shine Senior Vice President, President, Analytical Instruments
Age: 47
Bio & Compensation  - Reuters
Peter E. Hornstra Vice President, Chief Accounting Officer
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance